Memory-enhancing drugs: a molecular perspective.
Neurodegenerative diseases associated with dementia are characterized by cognitive deficits and memory impairment, thus stimulating research for memory enhancing drugs. We survey here the state of the art of research and clinical trials on these drugs from cholinesterase inhibitors and drugs acting on neurotransmitter receptors to drugs acting on gene expression.
Monti
Barbara
B
Department of Biology, University of Bologna, Via Selmi 3, 40126 Bologna, Italy.
Contestabile
Antonio
A
D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D008568:Memory / Q000187:drug effects*; D009446:Neurobiology; D018377:Neurotransmitter Agents / Q000378:metabolism; D018697:Nootropic Agents / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D018377:Neurotransmitter Agents; D018697:Nootropic Agents